Sameh Ghany-Abdel
Al Mansurah, DK 35516, Egypt
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction: Mohammed et al. Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach. Pharmaceuticals 2023, 16, 1123.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 26, 2025
Correction: Saber et al. BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis. Pharmaceuticals 2023, 16, 953.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 25, 2024
Satisfaction of academic medical staff with integrated medical curriculum: an exploratory multinational survey.
Journal: BMC medical education
Published: August 07, 2024
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitis.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: February 22, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenib.
Journal: Life sciences
Published: February 09, 2024
Tracking the therapeutic efficacy of a ketone mono ester and β-hydroxybutyrate for ulcerative colitis in rats: New perspectives.
Journal: Toxicology and applied pharmacology
Published: February 04, 2024
Alvespimycin Exhibits Potential Anti-TGF-β Signaling in the Setting of a Proteasome Activator in Rats with Bleomycin-Induced Pulmonary Fibrosis: A Promising Novel Approach.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: July 14, 2023
STA9090 as a Potential Therapeutic Agent for Liver Fibrosis by Modulating the HSP90/TβRII/Proteasome Interplay: Novel Insights from In Vitro and In Vivo Investigations.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 17, 2023
(R,R)-BD-AcAc2 Mitigates Chronic Colitis in Rats: A Promising Multi-Pronged Approach Modulating Inflammasome Activity, Autophagy, and Pyroptosis.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 27, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026